« Battleground FDA: How Tomorrow's Avandia Panel Could Help Shape The Future Of Diabetes | Main | Yaz and Yasmin birth control pills linked to 23 deaths, say Health Canada documents »

June 07, 2013

FDA panel votes to relax Avandia restrictions

Quoted from http://www.reuters.com/article/2013/06/06/us-avandia-fda-idUSBRE9540K120130606

FDA panel votes to relax Avandia restrictions

By David Morgan

WASHINGTON | Thu Jun 6, 2013 6:11pm EDT

WASHINGTON (Reuters) - U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmithKline's diabetes drug Avandia, the former blockbuster at the center of one of the biggest drug controversies in recent years.

The vote, by a divided Food and Drug Administration advisory committee of outside health experts, could modestly enlarge the market for Avandia in the United States and lay the groundwork for further research into the drug's health risks. FDA will now take the vote into consideration for a final decision on how the pill also known by the generic name rosiglitazone can be used.

[Article continues at original source]

Posted at 11:28 AM in Avandia |

Tags: Avandia, Dr. Steven Nissen, drug injury, drug recall, drug safety, FDA, heart problems

Comments

Search Engine

  • Google

    WWW
    www.drug-injury.com

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Free Case Evaluation


  • We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Drug Injury Watch

Thank You For Reading


Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.

* indicates required